or
forgot password

    • cancer clinical trials in marquette, MI

    • S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Pancreatic Cancer
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Marquette General Hospital
    Marquette, Michigan 49855
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Colorectal Cancer, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults, Pain, Psychosocial Effects of Cancer and Its Treatment
    Cognition in the Study of Tamoxifen and Raloxifene
    Marquette General Hospital
    Marquette, Michigan 49855
    Cognition, Aging
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    Marquette General Hospital
    Marquette, Michigan 49855
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients
    Marquette General Hospital
    Marquette, Michigan 49855
    Glioma, Meningioma